BGMA advocates ‘tailored’ approach to Statutory Scheme for branded medicinesÂ
The British Generic Manufacturers Association (BGMA) has backed the UK government's proposed changes to the Statutory Scheme for branded medicines, which includes a ‘Life...
Report: NHS faces over £1 billion loss as 85 biologics go off-patent in five years
The NHS is on track to miss out on savings of over a billion pounds as patents for a new lineup of 85 biologics...
BGMA backs move to analyse supply chain data to avoid overpricing of meds
The British Generic Manufacturers Association (BGMA) backs the government's decision to analyse quarterly sales and volume data from the whole supply chain, including manufacturers,...